SCHEDULE: Rosalind Advisors Discloses 9.9% Stake in Myomo

Rosalind Advisors, Inc. and its affiliates have jointly filed a Schedule 13G/A, reporting a beneficial ownership of 9.9% of Myomo, Inc.'s common stock.

Summary

• Rosalind Advisors, Inc., Rosalind Master Fund L.P., Steven Salamon, and Gilad Aharon have jointly filed an amended Schedule 13G, indicating their beneficial ownership of Myomo, Inc. common stock.
• The filing reports a total of 7,401,144 shares, representing 9.9% of the outstanding common stock as of July 31, 2026.
• This ownership includes 3,637,886 shares of common stock and 3,763,258 shares issuable upon exercise of pre-funded warrants.
• However, the exercise of these warrants is subject to a 'blocker provision' which prevents exercise if it would result in beneficial ownership exceeding 9.99%, meaning these warrants are currently unexercisable.
• Rosalind Advisors, Inc. acts as the investment advisor to Rosalind Master Fund L.P., and Steven Salamon is the portfolio manager for the advisor.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, primarily due to the disclosure of a significant ownership stake, but with caveats regarding exercisability of warrants and no new strategic information.

Positives

• Disclosure of a significant ownership stake (9.9%) in Myomo, Inc. by Rosalind Advisors and its affiliates.
• The reporting entities are established investment entities and individuals, suggesting a strategic investment approach.

Negatives

• The pre-funded warrants, which constitute a substantial portion of the reported ownership, are currently unexercisable due to a blocker provision limiting beneficial ownership to 9.99%.
• The filing does not provide any new strategic information or operational updates for Myomo, Inc.

Risks

• The unexercisable nature of the pre-funded warrants due to blocker provisions limits the immediate control or influence these securities represent.
• Potential for future changes in ownership or strategy by Rosalind Advisors, which could impact Myomo, Inc.'s stock.

Future Outlook

The filing itself does not contain forward-looking statements or guidance regarding Myomo, Inc.'s future performance. It solely pertains to ownership disclosure.

Management Comments

• Rosalind Advisors, Inc. is the investment advisor to RMF and may be deemed to be the beneficial owner of shares held by RMF.
• Steven Salamon is the portfolio manager of the Advisor and may be deemed to be the beneficial owner of shares held by RMF.
• The Advisor and Mr. Salamon disclaim beneficial ownership of the shares held by RMF.

Industry Context

StockSavvy.ai notes that Schedule 13G filings typically indicate passive investment stakes. However, the presence of pre-funded warrants with blocker provisions suggests a potentially more active interest or a strategy to manage ownership levels while maintaining economic exposure.

Stakeholder Impact

• Shareholders: May view the increased stake as a sign of confidence from a significant investor, but the unexercisable warrants temper immediate positive sentiment.
• Management: May need to engage with Rosalind Advisors regarding their intentions and strategy for Myomo, Inc.

Next Steps

• Monitoring of Rosalind Advisors' future actions and potential changes in their ownership stake in Myomo, Inc.
• Observing any potential exercise or modification of the pre-funded warrants, subject to blocker provisions.

Key Dates

Keywords

Myomo, Schedule 13G, Beneficial Ownership, Rosalind Advisors, Pre-funded Warrants, Blocker Provision, Investment Advisor, Portfolio Manager